Patent · US Active

Antibodies against ROR1 and uses thereof

US9266952B2 · kind B2 · utility

22Cited by

0References

6Claims

0Family size

Assignee

Kancera AB · SE

Inventor

Ingrid Teige · Lund, SE

Key dates

Filing date	Dec 12, 2011
Grant date	Feb 23, 2016
Priority date	—
Expiry date	May 24, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to antibodies for inducing cell death by the specific binding of (ROR1), domains thereof or nucleotide molecules encoding (ROR1). There are also provided methods involving and uses of the antibodies of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.